Unichem receives ANDA approval for Prasugrel Tablets
Prasugrel tablets are indicated to reduce the rate of thrombotic CV events
Prasugrel tablets are indicated to reduce the rate of thrombotic CV events
With India supplying around 60% of the world's vaccine needs and 20-22% of generic exports, the country is dedicated to providing affordable, high-quality drugs and contribute to global accessibility
Combating the prevalent stigma against TB in the society, India has been committed to providing, enabling and patient-centric support to all, individuals suffering from TB
Need to harmonize traditional and modern medicine to combat alarming health problems
Glenmark's current portfolio consists of 184 products authorized for distribution in the U.S. marketplace
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
India is committed to eliminating Lymphatic Filariasis by 2027, three years ahead of the global target through mission mode, multi partner, multi sector targeted drive
The medical device sector is considered as one of the sunrise sectors in the country
Reiterates India’s commitment to the BRICS TB Research Network Initiative
Subscribe To Our Newsletter & Stay Updated